Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Core Insights - The company has made significant progress in its portfolio over the last few years, particularly in international markets [1] - There has been a focus on supply chain management to ensure successful product launches in various markets outside the U.S. [1] - Recent quarters have shown success in gaining traction in new markets, with multiple new product launches contributing to this growth [1] - A notable portion of the success is attributed to products related to obesity and self-pay models, with valuable insights gained from these experiences in both the U.S. and international markets [1]